Peter S. Pang
About
Peter S. Pang is a scholar working on Cardiology and Cardiovascular Medicine, Emergency Medicine and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Peter S. Pang has authored 182 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Cardiology and Cardiovascular Medicine, 55 papers in Emergency Medicine and 36 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter S. Pang's work include Heart Failure Treatment and Management (117 papers), Cardiovascular Function and Risk Factors (49 papers) and Emergency and Acute Care Studies (32 papers). Peter S. Pang is often cited by papers focused on Heart Failure Treatment and Management (117 papers), Cardiovascular Function and Risk Factors (49 papers) and Emergency and Acute Care Studies (32 papers). Peter S. Pang collaborates with scholars based in United States, Italy and Netherlands. Peter S. Pang's co-authors include Mihai Gheorghiade, Sean P. Collins, Gregg C. Fonarow, G. Michael Felker, Mihai Gheorghiade, Gerasimos Filippatos, Marco Metra, Adriaan A. Voors, Gad Cotter and Robb D. Kociol and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.
In The Last Decade
Peter S. Pang
169 papers receiving 5.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Peter S. Pang United States | 37 | 4.5k | 1.2k | 857 | 837 | 570 | 182 | 6.0k | ||
| Étienne Gayat France | 40 | 2.7k 0.6× | 956 0.8× | 1.6k 1.8× | 711 0.8× | 726 1.3× | 228 | 6.0k | ||
| Wendy Gattis Stough United States | 40 | 6.2k 1.4× | 1.8k 1.4× | 645 0.8× | 535 0.6× | 602 1.1× | 79 | 7.9k | ||
| Nicolas Girerd France | 37 | 3.9k 0.9× | 1.3k 1.1× | 1.4k 1.7× | 316 0.4× | 505 0.9× | 346 | 5.9k | ||
| Andrew P. Ambrosy United States | 36 | 4.9k 1.1× | 1.2k 1.0× | 848 1.0× | 362 0.4× | 516 0.9× | 200 | 6.3k | ||
| James McCord United States | 32 | 5.9k 1.3× | 1.2k 1.0× | 1.0k 1.2× | 883 1.1× | 512 0.9× | 122 | 7.3k | ||
| Ovidiu Chioncel Romania | 24 | 4.2k 0.9× | 797 0.6× | 640 0.7× | 356 0.4× | 517 0.9× | 107 | 5.0k | ||
| Phillip D. Levy United States | 36 | 2.5k 0.6× | 450 0.4× | 695 0.8× | 649 0.8× | 290 0.5× | 253 | 4.6k | ||
| W. Frank Peacock United States | 46 | 6.6k 1.5× | 1.5k 1.2× | 1.7k 1.9× | 1.3k 1.6× | 866 1.5× | 404 | 9.4k | ||
| F. Perry Wilson United States | 40 | 1.8k 0.4× | 1.6k 1.3× | 1.1k 1.2× | 419 0.5× | 244 0.4× | 181 | 5.8k | ||
| Beth A. Davison United States | 45 | 4.5k 1.0× | 1.5k 1.2× | 973 1.1× | 412 0.5× | 510 0.9× | 156 | 6.6k |
Countries citing papers authored by Peter S. Pang
Since
Specialization
Citations
This map shows the geographic impact of Peter S. Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter S. Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter S. Pang more than expected).
Fields of papers citing papers by Peter S. Pang
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Peter S. Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter S. Pang. The network helps show where Peter S. Pang may publish in the future.
Co-authorship network of co-authors of Peter S. Pang
This figure shows the co-authorship network connecting the top 25 collaborators of Peter S. Pang. A scholar is included among the top collaborators of Peter S. Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter S. Pang. Peter S. Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Pang, Peter S., Olena Mazurenko, Nancy Glober, et al.. (2025). Use of Hallway Beds, Radiology Studies, and Patients in Pain on Arrival to the Emergency Department Are Associated With Patient Experience. Annals of Emergency Medicine. 86(2). 150–157.
2.
Daniels, Lori B., Robert H. Christenson, Carol L. Clark, et al.. (2024). Clinical Performance of an N-Terminal Pro-B-Type Natriuretic Peptide Assay in Acute Heart Failure Diagnosis. The Journal of Applied Laboratory Medicine. 10(2). 325–338.
3.
Pagnesi, Matteo, Marianna Adamo, Jozine M. ter Maaten, et al.. (2023). Impact of Mitral Regurgitation in Patients with Acute Heart Failure: Insights from the RELAX-AHF-2 Trial. European Journal of Heart Failure. 25(4). 541–552.
4.
Pugliese, Nicola Riccardo, Matteo Mazzola, Giulia Bandini, et al.. (2023). Prognostic Role of Sonographic Decongestion in Patients with Acute Heart Failure with Reduced and Preserved Ejection Fraction: A Multicentre Study. Journal of Clinical Medicine. 12(3). 773–773.
5.
Beldhuis, Iris E., Jozine M. ter Maaten, Sylwia M. Figarska, et al.. (2023). Disconnect between the effects of serelaxin on renal function and outcome in acute heart failure. Clinical Research in Cardiology. 112(7). 901–910.
6.
Han, Jin H., Candace D. McNaughton, William B. Stubblefield, et al.. (2022). Delirium and its association with short-term outcomes in younger and older patients with acute heart failure. PLoS ONE. 17(7). e0270889–e0270889.
7.
Mebazaa, Alexandre, Beth A. Davison, Ovidiu Chioncel, et al.. (2022). Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. The Lancet. 400(10367). 1938–1952.
8.
Emmens, Johanna E., Jozine M. ter Maaten, Yuya Matsue, et al.. (2021). Worsening renal function in acute heart failure in the context of diuretic response. European Journal of Heart Failure. 24(2). 365–374.
9.
Gargani, Luna, Nicola Riccardo Pugliese, Francesca Frassi, et al.. (2021). Prognostic Value of Lung Ultrasound in Patients Hospitalized for Heart Disease Irrespective of Symptoms and Ejection Fraction. ESC Heart Failure. 8(4). 2660–2669.
10.
Teerlink, John R., Marco Metra, Gad Cotter, et al.. (2020). Relationship Between Left Ventricular Ejection Fraction and Cardiovascular Outcomes Following Hospitalization for Heart Failure: Insights from the RELAX-AHF-2 Trial. European Journal of Heart Failure. 22(4). 726–738.
11.
Collins, Sean P. & Peter S. Pang. (2019). ACUTE Heart Failure Risk Stratification: A Step Closer to the Holy Grail?. PMC.
12.
Boustani, Malaz, Lindsey Yourman, Richard J. Holden, Peter S. Pang, & Craig A. Solid. (2019). A Profile in Population Health Management: The Sandra Eskenazi Center for Brain Care Innovation. IUScholarWorks (Indiana University).
13.
Januzzi, James L., Annabel Chen‐Tournoux, Robert H. Christenson, et al.. (2018). N-Terminal Pro–B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study. Publisher.
14.
Cotter, Gad, Adriaan A. Voors, Margaret F. Prescott, et al.. (2015). Growth Differentiation Factor 15 (GDF-15) in Patients Admitted for Acute Heart Failure: Results from the RELAX-AHF Study. European Journal of Heart Failure. 17(11). 1133–1143.
15.
Alexander, Pauline, et al.. (2014). Lack of evidence for intravenous vasodilators in ED patients with acute heart failure: a systematic review. The American Journal of Emergency Medicine. 33(2). 133–141.
16.
Spertus, John A., Alan B. Miller, S. Ward Casscells, et al.. (2013). Association of Low Body Temperature and Poor Outcomes in Patients Admitted with Worsening Heart Failure: A Substudy of the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) Trial. European Journal of Heart Failure. 15(12). 1382–1389.
17.
Girerd, Nicolas, Peter S. Pang, Karl Swedberg, et al.. (2013). Serum Aldosterone is Associated with Mortality and Re-Hospitalization in Patients with Reduced Ejection Fraction Hospitalized for Acute Heart Failure: Analysis from the EVEREST Trial. European Journal of Heart Failure. 15(11). 1228–1235.
18.
Collins, Sean P., Peter S. Pang, Christopher J. Lindsell, et al.. (2010). International Variations in the Clinical, Diagnostic, and Treatment Characteristics of Emergency Department Patients with Acute Heart Failure Syndromes. European Journal of Heart Failure. 12(11). 1253–1260.
19.
Gheorghiade, Mihai & Peter S. Pang. (2009). Acute Heart Failure Syndromes. Journal of the American College of Cardiology. 53(7). 557–573.
20.
Pang, Peter S., et al.. (2006). How to evaluate the patient with syncope. Emergency Medicine Australasia. 38(7). 15–21.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Étienne Gayat Breakdown of academic impact, for papers by Wendy Gattis Stough Breakdown of academic impact, for papers by Nicolas Girerd Breakdown of academic impact, for papers by Andrew P. Ambrosy Breakdown of academic impact, for papers by James McCord Breakdown of academic impact, for papers by Ovidiu Chioncel Breakdown of academic impact, for papers by Phillip D. Levy Breakdown of academic impact, for papers by W. Frank Peacock Breakdown of academic impact, for papers by F. Perry Wilson Breakdown of academic impact, for papers by Beth A. Davison